mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.08 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.08 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.08 |